Tracking and Analyzing Medical Countermeasures for Emerging Health Challenges: Mpox

Tracking and Analyzing Medical Countermeasures for Emerging Health Challenges: Mpox

Our Reports
The COVID-19 pandemic exposed significant global inequities in the access to therapeutics, vaccines, testing, and other medical interventions that could limit the range and impact of the disease. These global inequities are not limited to the COVID-19 pandemic and need to be critically addressed in the ongoing mpox outbreak. Through Quickstart, we aim to serve as an external, independent source for tracking actions to meet commitments, catalyzing additional commitments to meet the need, and holding the world to account for the mpox response. Access the full report.
Read More

Experiences, Enablers, and Challenges in Service Delivery and Integration of COVID-19 Vaccines: a Rapid Systematic Review

Our Reports
Abstract: The COVID-19 vaccination is a crucial public health intervention for controlling the spread and severity of the SARS-CoV2 virus. COVID-19 vaccines have been developed in record time, but their deployment has varied across countries, owing to differences in health system capacity, demand for the vaccine, and purchasing power of countries. The aim of this rapid review is to summarize and synthesize experiences on COVID-19 vaccine service delivery and integration to inform future COVID-19 vaccination programming and contribute to the knowledge base for future pandemic management. a systematic search was conducted in PubMed, Scopus, and Global Index Medicus databases. Twenty-five studies were included in the analysis. Included studies spanned nine countries where COVID-19 vaccines were delivered through mass, mobile, and fixed-post vaccination service delivery models. There was limited evidence of…
Read More
COVID GAP Accountability Report, Issue 24

COVID GAP Accountability Report, Issue 24

Our Reports
April 19, 2023: COVID GAP Accountability Report Issue 24 Key Changes and Insights Since Previous Report: On April 17th, India reported over 9,000 new COVID-19 cases prompting some parts of the country to reintroduce mask mandates. The XBB.1.16 variant now accounts for roughly 7.2% of sequenced COVID-19 cases in the United States. The World Health Organization’s technical advisory group on COVID vaccine composition met in March to review the performance of updated COVID-19 vaccines. The group released a statement saying that the updated vaccines that contain either BA.1 or BA.4/5 provide better protection than vaccines that contain only the original virus. The FDA authorized a second bivalent COVID-19 vaccine for seniors ages 65+ and those with compromised immune systems. The Duke Global Health Innovation Center is a proud partner of the COVID…
Read More
COVID GAP Accountability Report, Issue 23

COVID GAP Accountability Report, Issue 23

Our Reports
April 5, 2023: COVID GAP Accountability Report Issue 23 Key Changes and Insights Since Previous Report: India reported over 3,600 new COVID-19 cases on April 3rd. This represents the largest single day increase in new cases in over 6 months. The World Health Organization is monitoring the XBB.1.16 subvariant that is currently circulating in India. The European Medicines Agency (EMA) and the Committee for Medicinal Products for Human Use (CHMP) have authorized the use of Bimervax as a COVID-19 booster vaccine. Bimervax is a bivalent, recombinant protein vaccine. South Korea plans to start using wastewater surveillance to monitor the spread of COVID-19 in the country. The health systems and response pillar of ACT-A has received $10 million in additional funding, and is now 35.9% funded. Botswana has achieved 70% vaccination…
Read More
COVID GAP Accountability Report, Issue 22

COVID GAP Accountability Report, Issue 22

Our Reports
March 22, 2023: COVID GAP Accountability Report Issue 22 Key Changes and Insights Since Previous Report: The Pandemic Fund received over 600 proposals in response to the call for expression of interests (EOI) for the first round of funding. The fund has $300 million available for the first round, but requests from the EOI total over $5.5 billion. The 5th meeting of the Intergovernmental Negotiating Body (INB) will take place April 3- 6. Laos, Malawi, Rwanda and Zambia have received oral antiviral treatments for high-risk patients through COVID Treatment Quick Start Consortium. The Duke Global Health Innovation Center is a proud partner of the COVID Global Accountability Platform (COVID GAP).  COVID GAP’s Accountability Reports highlight and analyze recent developments, track progress toward national, regional, and global targets, and identify high-priority recommendations for…
Read More
COVID GAP Accountability Report, Issue 21

COVID GAP Accountability Report, Issue 21

Our Reports
March 1, 2023: COVID GAP Accountability Report Issue 21 Key Changes and Insights Since Previous Report: The Pandemic Fund closed their call for expressions of interest on February 24th. The first call for proposals is expected to be announced in early March and applicants will have 11 weeks to submit proposals. The Governing Board plans to make funding decisions in July 2023. The Global Preparedness Monitoring Board has released a document outlining 3 tests to ensure the success of key pandemic prevention, preparedness, and response reforms. The fourth meeting of the WHO Intergovernmental Negotiating Body will run from February 27th to March 3rd. Discussion will focus on the zero draft of the Pandemic Treaty. Dr. Jean Kaseya has been selected as the first Director General of the Africa Centers for…
Read More
COVID GAP Accountability Report, Issue 20

COVID GAP Accountability Report, Issue 20

Our Reports
February 16, 2023: COVID GAP Accountability Report Issue 20 Key Changes and Insights Since Previous Report: The Pandemic Fund Governing Board has approved $300 million in financing for the first round of funding. The first round will prioritize projects that focus on strengthening disease surveillance and early warning laboratory systems, and health workforce capacity. The WHO has released the zero draft of pandemic treaty (WHO CA+) which will be discussed in Geneva from Feb. 27 to March 3. The draft does not include any mechanism for independent accountability and oversight mechanisms are set to be discussed at the first meeting of the governing body. Dr. Muhammad Ali Pate has been selected as GAVI’s next CEO. The Global Fund has awarded an additional $320 million in funding towards pandemic preparedness and…
Read More
COVID GAP Accountability Report, Issue 19

COVID GAP Accountability Report, Issue 19

Our Reports
February 2, 2023: COVID GAP Accountability Report Issue 19 Key Changes and Insights Since Previous Report: Chad is reporting a 0.30% daily vaccination rate (28-day average) which is an increase from 0.00% in the previous report. Chad is reporting 100% vaccination coverage of the 60+ population, which is an increase from 78.37% two weeks ago. Tanzania is reporting that 68.77% of the healthcare worker population has been vaccinated which is an increase from 40.73%. Tanzania is also reporting 100% vaccination coverage of the 60+ population, an increase from 9.90% in the previous report. Uganda is reporting that 100% of the 60+ population has been vaccinated, an increase from 36.19% in the previous report. The number of booster doses administered per 100 people has increased slowly across all income levels as follows:…
Read More
COVID GAP Accountability Report, Issue 18

COVID GAP Accountability Report, Issue 18

Our Reports
January 19, 2023: COVID GAP Accountability Report Issue 18 Key Changes and Insights Since Previous Report: The number of booster doses administered per 100 people has increased across all income levels as follows: High income increased to 47.31 from 47.21 Upper middle income increased to 24.64 from 24.46 Lower middle income increased to 17.55 from 17.36 Low income increased to 3.29 from 2.98 Nigeria is reporting 71.01% vaccination coverage of the 60+ population, which is an increase from 65.98% two weeks ago. South Sudan is reporting 53.95% vaccination coverage of the 60+ population, which is an increase from 51% two weeks ago. Sierra Leone is reporting a 0.27% daily vaccination rate (28-day average), an increase from 0.18% in the previous report. Malawi is reporting a 0.08% daily vaccination rate (28-day average),…
Read More
COVID GAP Accountability Report, Issue 17

COVID GAP Accountability Report, Issue 17

Our Reports
January 5, 2023: COVID GAP Accountability Report Issue 17 Key Changes and Insights Since Previous Report: China has rolled back its zero-COVID policies, and there is a lack of accurate data available regarding COVID deaths or circulating variants. Airfinity’s model predicts there will be 1.7 million deaths by the end of April 2023. Amidst the COVID-19 surge in China, several countries have implemented travel requirements for travelers coming from China. The U.S. and U.K. are requiring pre-flight COVID tests while Morocco is implementing a full entry ban. Singapore announced a pledge of USD $1 million to the Global Fund. Nigeria is reporting 65.98% vaccination coverage of their 60+ population which is an increase from 56.49% two weeks ago. The Democratic Republic of the Congo is reporting 81.92% vaccination coverage of their…
Read More